To identify novel Gli-responsive genes, CRC HT-29 cells, which are widely used as Hh-responsive cells32,33, were treated with the small molecule Gli inhibitor GANT61 or subjected to ectopic expression of Gli2, and the gene expression profiles were determined by next-generation sequencing. This evidence concerns the gene GLI2 and colorectal carcinoma.